11th April 2018: Proton Partners International announced today it has treated the first patient in the UK with high energy proton beam therapy.
20th March 2018: Proton Partners International has been granted formal technical and regulatory approval from Healthcare Inspectorate Wales to begin treating patients with proton beam therapy at its Rutherford Cancer Centre in Wales.
12th March 2018: IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three new contracts with Proton Partners International, to install three Proteus®ONE* compact proton therapy solutions across the UK.
7th March 2018: Wales has shown ‘outstanding’ vision in helping to develop innovative proton beam therapy services for cancer patients.
22nd February 2018: Proton Partners International and Ion Beam Applications (IBA) Group, the world’s leading developers of high energy proton beam therapy centres and systems, have officially completed testing on the UK’s first high energy proton beam machine, the Proteus®ONE.
6th February 2018: The first proton beam therapy system to be installed in the North-East of England was delivered today by Proton Partners International Ltd.
4th February 2018: The UK needs to take a ‘giant leap of faith’ in cancer care if it is to avoid falling behind in the development of innovative treatments.
8th January 2018: Proton Partners International, the world’s leading developer of high energy proton beam therapy centres, has officially marked the start of work on its fourth UK-based oncology centre.
11th December 2017: Proton Partners International Ltd., the company bringing high energy proton beam therapy to the UK, has today announced a new construction partnership for its £35 million oncology centre, which will be known as the Rutherford Cancer Centre North West.
5th December 2017: The creation of the first proton beam therapy cancer treatment centre to be built in the United Arab Emirates took a significant step forward today, as work officially began on site.